Published on 01/19/2026 at 01:52 am EST
(MT Newswires) -- Japanese shares started the week lower after U.S. President Donald Trump threatened additional tariffs on eight European countries, a move that weighed on investor sentiment.
The Nikkei 225 fell 352.60 points or 0.7% to close at 53,583.57.
EU ambassadors agreed on Sunday to step up efforts to deter U.S. President Donald Trump from imposing tariffs on European allies, while preparing countermeasures if the duties proceed, EU diplomats said.
Trump said he would impose escalating tariffs from Feb. 1 on several EU countries, Britain and Norway unless the U.S. is allowed to buy Greenland. EU leaders are due to discuss responses at an emergency summit in Brussels on Thursday, including possible tariffs on U.S. imports or use of the bloc's anti-coercion tool.
In economic news, machinery orders at 280 Japanese manufacturers rose 8.5% in November from the previous month on a seasonally adjusted basis, government data showed, while core private-sector orders excluding ships and power utilities fell 11%.
Separately, retail sales rose 1% from a year earlier in November, easing from October but extending growth to a third straight month. On a seasonally adjusted basis, sales gained 0.6% from the previous month.
Japan's industrial production fell 2.7% in November from the previous month and 2.2% from a year earlier, revised data showed, with shipments and inventories also declining.
Separately, the tertiary industry activity index slipped 0.2% month on month but rose 1.7% from a year earlier, as gains in personal services offset weakness in business services.
On the corporate front, Toho Holdings , which climbed 3.4%, said 3D Investment Partners plans to buy up to 1.54 million shares, capping its stake at 27%, subject to board and regulatory approvals.
Allied Telesis , which ended 2% lower, said it will transfer its U.S. IP triple-play services business to Warrior Communications, with the cash deal effective Feb. 27 and expected to generate extraordinary income in fiscal 2026.
Veritas In Silico, which jumped 16.7%, said a patent application for an ALS nucleic acid therapy targeting TDP-43 splicing isoforms has been published, with the company as sole applicant using its AI platform ibVIS.

Sumber : MT Newswires